Caplin Point Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	6,210	1,995	1,387	1,776	1,508
Short-Term Investments	-	3,857	5,893	5,602	4,525	3,100
Trading Asset Securities	-	-	964.5	359.9	202.7	519.7
Cash & Short-Term Investments	10,068	10,068	8,852	7,348	6,503	5,127
Cash Growth	11.52%	13.73%	20.47%	13.00%	26.83%	14.89%
Accounts Receivable	-	8,258	6,404	5,453	3,987	3,207
Other Receivables	-	741.7	629	480.8	204.5	136.1
Receivables	-	9,000	7,033	5,934	4,191	3,343
Inventory	-	4,289	3,361	3,630	2,882	2,273
Prepaid Expenses	-	-	136	18	23.7	-
Other Current Assets	-	2,501	1,957	1,999	1,922	2,235
Total Current Assets	-	25,857	21,340	18,929	15,522	12,978
Property, Plant & Equipment	-	7,598	6,737	5,568	4,894	2,935
Long-Term Investments	-	4,733	1,963	1,326	709.1	380.9
Goodwill	-	-	27.7	27.7	27.7	0.5
Other Intangible Assets	-	538.3	127.8	97.5	84	108
Long-Term Deferred Tax Assets	-	79.7	22.3	125.5	140	62.1
Other Long-Term Assets	-	1,650	1,861	907.3	537.8	899
Total Assets	-	40,455	32,079	26,981	21,914	17,363
Accounts Payable	-	2,960	2,176	2,296	1,526	1,559
Accrued Expenses	-	200.2	401.5	296.6	249.2	142.4
Current Portion of Long-Term Debt	-	5.7	5.5	2.8	34.1	5
Current Portion of Leases	-	19.8	15.6	7.7	11.4	4.6
Other Current Liabilities	-	673.4	461.5	705.2	859.7	365.4
Total Current Liabilities	-	3,859	3,060	3,309	2,680	2,077
Long-Term Leases	-	20.6	29.1	9.2	9.3	11.7
Long-Term Unearned Revenue	-	130.8	108.2	76.1	45.2	61.1
Pension & Post-Retirement Benefits	-	-	8.5	4.3	-	60.6
Long-Term Deferred Tax Liabilities	-	126	-	-	-	-
Other Long-Term Liabilities	-	10	8.9	114.8	106.8	54.2
Total Liabilities	-	4,147	3,215	3,513	2,841	2,264
Common Stock	-	152	152	151.9	151.8	151.6
Additional Paid-In Capital	-	-	193.6	154.1	134.1	146.3
Retained Earnings	-	-	23,803	19,740	15,511	12,025
Comprehensive Income & Other	-	34,966	2,191	945.4	842.4	350.8
Total Common Equity	35,118	35,118	26,339	20,991	16,639	12,674
Minority Interest	-	443.8	359	311.2	267.9	259.5
Shareholders' Equity	36,308	36,308	28,864	23,468	19,073	15,099
Total Liabilities & Equity	-	40,455	32,079	26,981	21,914	17,363
Total Debt	46.1	46.1	50.2	19.7	54.8	21.3
Net Cash (Debt)	10,021	10,021	8,802	7,329	6,448	5,106
Net Cash Growth	11.63%	13.85%	20.11%	13.66%	26.29%	19.33%
Net Cash Per Share	131.48	131.45	115.29	96.04	84.28	66.85
Filing Date Shares Outstanding	76.02	76.01	76.01	75.94	75.9	75.79
Total Common Shares Outstanding	76.02	76.01	76.01	75.94	75.9	75.79
Working Capital	-	21,997	18,280	15,621	12,842	10,901
Book Value Per Share	462.02	462.02	346.52	276.41	219.22	167.22
Tangible Book Value	34,580	34,580	26,184	20,866	16,527	12,565
Tangible Book Value Per Share	454.94	454.94	344.47	274.77	217.74	165.79
Land	-	-	572.8	378.5	377.5	338.7
Buildings	-	-	1,642	1,452	1,136	1,073
Machinery	-	-	6,071	4,936	3,067	2,874
Construction In Progress	-	-	1,392	1,166	2,205	154.1